MedTrace Logo

Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

NCT03587415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-07-16

No results posted yet for this study

Summary

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Conditions

  • Polycystic Ovary Syndrome

Interventions

DIAGNOSTIC_TEST

preptin and amylin level

we will take both of group blood samples to compare them serum preptin and amylin

Sponsors & Collaborators

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Principal Investigators

  • Senol sentürk, PhD · Recep Tayyip Erdogan University

Eligibility

Min Age
17 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2017-11-30
Completion
2017-12-07

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587415 on ClinicalTrials.gov